Hypoxic exposure of AML LSCs promotes chemoresistance to cytarabine arabinoside (Ara-C) via upregulation of the Polycomb transcriptional repressors BMI-1, which in turn supports malignancy via activation of PI3K/Akt signaling and EMT programs (95). Here, AKT1 is linked to acute myeloid leukemia.